Performance of contrast-enhanced cone-beam breast CT to predict nipple–areolar complex involvement in early-stage breast cancer - Scorecard - MDSpire

Performance of contrast-enhanced cone-beam breast CT to predict nipple–areolar complex involvement in early-stage breast cancer

  • By

  • Jie Huang

  • Ni He

  • Jiao Li

  • Jieting Chen

  • Canyu Guan

  • Yaopan Wu

  • Qianyi Lu

  • July 1, 2025

  • 0 min

Share

Clinical Scorecard: Efficacy of Contrast-Enhanced Cone-Beam Breast CT in Assessing Nipple–Areolar Complex Involvement in Early Breast Cancer

At a Glance

CategoryDetail
ConditionNipple–areolar complex (NAC) involvement in early breast cancer
Key MechanismsPreoperative imaging assessment using contrast-enhanced cone-beam breast CT (CE-CBBCT) to detect NAC involvement
Target PopulationPatients with early-stage operable breast cancer undergoing preoperative evaluation
Care SettingBreast cancer diagnostic and surgical planning in tertiary cancer centers

Key Highlights

  • NAC involvement incidence ranges from 8% to 27.7%, contraindicating nipple-sparing mastectomy (NSM).
  • CE-CBBCT offers no compression imaging, rapid acquisition, and simultaneous assessment of microcalcifications and contrast enhancement.
  • CE-CBBCT is FDA, Chinese National Medical Products Administration, and EU approved and integrated into routine clinical practice.

Guideline-Based Recommendations

Diagnosis

  • Use CE-CBBCT to preoperatively evaluate NAC involvement in early breast cancer patients.
  • Assess imaging features including asymmetric NAC enhancement, nipple retraction, periareolar skin thickening, and suspicious calcifications within 2 cm.
  • Combine clinical, pathological, and imaging data for comprehensive NAC involvement assessment.

Management

  • Avoid nipple-sparing mastectomy in patients with clinical or radiological evidence of NAC involvement.
  • Use CE-CBBCT findings to guide surgical planning and patient counseling.

Monitoring & Follow-up

  • Perform CE-CBBCT scanning with standardized protocols including two-phase enhanced scanning after iodine contrast injection.
  • Ensure imaging interpretation by trained radiologists with experience in CBBCT.

Risks

  • Potential false negatives or positives in NAC involvement assessment may affect surgical decisions.
  • Radiation exposure inherent to CT imaging should be considered.

Patient & Prescribing Data

Early-stage breast cancer patients undergoing preoperative imaging assessment

CE-CBBCT provides accurate imaging to predict NAC involvement, aiding in surgical decision-making and potentially improving patient psychological outcomes by enabling safe NSM when appropriate.

Clinical Best Practices

  • Select patients for CE-CBBCT based on clinical indications such as MRI contraindications or need for calcification assessment.
  • Position patients prone with elevated arms during scanning to optimize breast imaging.
  • Use standardized contrast injection protocols and scanning parameters for reproducible imaging quality.
  • Ensure radiologists interpreting CE-CBBCT images are trained and blinded to pathological outcomes to reduce bias.
  • Incorporate propensity score matching in research to balance confounding factors when evaluating diagnostic performance.

References

Original Source(s)

Related Content